License-Out
License Agreement between NACALAI TESQUE, INC. and iPS Academia Japan, Inc.
iPS Academia Japan, Inc. has entered into a non-exclusive license agreement with NACALAI TESQUE, INC. (Kyoto, Japan) to provide products and services related to iPS cell-derived cardiomyocytes for research use, based on the patents related to iPS cell technology that have been sublicensed to iPS Academia Japan, Inc. by Kyoto University.
